
Bioventus BVS
$ 7.5
-0.66%
Quarterly report 2025-Q3
added 11-04-2025
Bioventus Long Term Debt Current 2011-2025 | BVS
Annual Long Term Debt Current Bioventus
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.06 M | 3.55 M | 3.5 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.06 M | 3.5 M | 3.7 M |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Brainsway Ltd.
BWAY
|
824 K | $ 17.13 | 1.66 % | $ 99.4 M | ||
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
DarioHealth Corp.
DRIO
|
111 K | $ 12.15 | 2.14 % | $ 345 M | ||
|
DexCom
DXCM
|
21.1 M | $ 66.06 | -1.34 % | $ 25.5 B | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Exact Sciences Corporation
EXAS
|
27.4 M | $ 101.57 | 0.07 % | $ 18.8 B | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
2.99 M | $ 1.56 | -3.7 % | $ 1.98 M | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 38.95 | 0.82 % | $ 1.08 B | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
173 M | $ 227.29 | 0.42 % | $ 166 B | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 26.94 | -0.74 % | $ 815 M | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
29.8 M | $ 1 408.65 | 1.08 % | $ 29.9 B | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
NeoGenomics
NEO
|
3.38 M | $ 12.15 | 2.53 % | $ 1.54 B | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 6.84 | -0.36 % | $ 1.48 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
5.94 M | $ 19.9 | -3.21 % | $ 1.07 B | ||
|
Pacific Biosciences of California
PACB
|
9.59 M | $ 2.12 | - | $ 538 M | ||
|
Celcuity
CELC
|
172 K | $ 101.74 | -3.33 % | $ 4.01 B | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
29 K | $ 3.35 | -6.42 % | $ 107 K | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 26.46 | -0.62 % | $ 20 B | ||
|
Co-Diagnostics
CODX
|
838 K | $ 0.3 | -13.39 % | $ 8.8 M | ||
|
Precipio
PRPO
|
218 K | $ 24.67 | -1.2 % | $ 32 M | ||
|
IQVIA Holdings
IQV
|
99 M | $ 224.13 | 0.84 % | $ 40.6 B | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | $ 45.14 | -0.21 % | $ 10 B | ||
|
Guardant Health
GH
|
29.2 M | $ 103.55 | 1.45 % | $ 12.7 B | ||
|
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M | ||
|
Sotera Health Company
SHC
|
5.06 M | $ 16.76 | -0.42 % | $ 4.74 B | ||
|
Soleno Therapeutics
SLNO
|
526 K | $ 49.79 | -4.25 % | $ 2 B | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Thermo Fisher Scientific
TMO
|
261 M | $ 574.27 | 0.46 % | $ 219 B | ||
|
Illumina
ILMN
|
79 M | $ 134.66 | -0.16 % | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
54.2 M | $ 197.59 | 2.36 % | $ 10.2 B | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | $ 31.39 | 1.47 % | $ 1.88 B | ||
|
Quotient Limited
QTNT
|
3.45 M | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
173 M | $ 184.04 | 0.81 % | $ 20.4 B | ||
|
Biodesix
BDSX
|
719 K | $ 7.63 | -2.8 % | $ 989 M | ||
|
Myriad Genetics
MYGN
|
12.8 M | $ 7.07 | -2.01 % | $ 641 M |